close
Add to watchlist
Nanosphere Inc (NSPH)
Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Its proprietary nanoparticle technology enables earlier detection of diseases through ultra-sensitive protein detection; and provides the ability to run multiple tests at the same time on the same sample. The company is developing diagnostic tests for markers, which reveal the existence of various medical conditions, including cancer, cardiovascular, respiratory, autoimmune, neurodegenerative, and infectious diseases, as well as for pharmacogenomics. It also involves in developing and commercializing genomic and protein assays, including hyper-coagulation, warfarin metabolism, cystic fibrosis, respiratory virus panel, hemochromatosis, blood infection panel, human papillomavirus, cardiac troponin I, prostate specific antigen, and biomarker validation; and RF & Anti-CCP, a test for the earlier diagnosis of rheumatoid arthritis. The company was founded in 1998 and is headquartered in Northbrook, Illinois.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 1.92 |
| Volume | 46082 |
| Volume Avg | 200497 |
| 52 Week High | 3.60 |
| 52 Week Low | 0.89 |
| PE | N/A |
| PE (group average) | N/A |
| EPS Year | -1.01 |
| EPS change Q/Q | -18.52% |
| EPS change Q/Q Yr ago | -3.23% |
| EPS change Q/Q next Q est | -52.38% |
| EPS change Y/Y | -5.41% |
| REV change Q/Q | 100% |
| REV change Q/Q Yr ago | -25% |
| EPS next Q est | -0.21 |
| EPS next Y est | -0.59 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |